Posted in: Ingredient Buyer Guides
Quick answer: A ginkgo extract COA should identify the tested lot, the ginkgolic-acid analytes covered, the result, units, analytical method and reporting limits. “Not detected” is not a numerical zero. Before accepting a lot, compare the method’s detection and quantification capability with the agreed specification, then apply your quality team’s approved decision rule.
This guide is for supplement procurement and QA teams comparing Ginkgo Biloba Extract offers. A Ginkgo extract COA review should keep ginkgolic-acid results separate from the extract’s marker profile. GNB’s product information identifies leaf identity, flavone glycosides, terpene lactones and ginkgolic-acid control as distinct review items. This article explains how to turn the ginkgolic-acid part of that review into a documented purchasing decision; it does not prescribe a universal regulatory limit or confirm a current GNB batch result.
Keep marker content and ginkgolic-acid control separate on a Ginkgo extract COA
Flavone glycosides and terpene lactones describe different marker groups within a standardized ginkgo extract. Their reported contents do not establish the ginkgolic-acid result. A bulk quotation that gives only marker percentages leaves an important quality question unanswered. Equally, a low ginkgolic-acid result does not establish botanical authenticity, the complete marker profile or suitability for a finished product.
Request the exact offered grade, botanical identity and plant part, extraction information, composition declaration and current specification. For each analytical line, record the named analyte or group, method and reporting basis. Clarify whether a result represents a defined sum of ginkgolic acids, selected individual compounds or another stated scope. Two reports with the same heading may cover different analytes.
Read LOD and LOQ on a Ginkgo extract COA
The limit of detection (LOD) concerns detecting an analyte under the method’s stated conditions. The limit of quantification (LOQ) concerns the level that can be quantified with the method’s defined performance. Ask the laboratory to explain its terminology and reporting convention for the extract matrix. An instrument’s general sensitivity claim does not by itself establish the capability of the complete method used on your sample.
| What the report says | What it establishes | What the buyer should request |
|---|---|---|
| A numerical result | A reported measured amount on the stated basis. | Analyte scope, units, method, quantification capability and the applicable acceptance rule. |
| Not detected or ND | A result interpreted using the laboratory’s detection and reporting convention. | The definition of ND and the relevant numerical reporting threshold; do not record it as zero. |
| Below LOQ | The amount was not quantified at or above the stated LOQ; this is not a precise concentration. | The LOQ value, units and any distinction between detected but unquantified and not detected. |
| Pass or complies | A conclusion against a criterion that should be identified. | The specification revision, applicable limit, result details and decision rule behind the conclusion. |
| A blank field | No interpretable result for that field. | Clarification of whether testing was performed, omitted or reported in another document. |
Do not infer that ND, below LOQ and pass are interchangeable. If the report omits the threshold needed for comparison, hold the acceptance decision for clarification rather than filling the gap with an assumed value.
Worked example: an inadequate limit on a Ginkgo extract COA
Hypothetical training example only: suppose a buyer’s approved purchasing specification sets a maximum of 2 mg/kg for a defined sum of ginkgolic acids. These numbers are invented for the example; they are not a legal standard, recommended universal limit or GNB product specification.
- Report A states “below 5 mg/kg,” with an LOQ of 5 mg/kg. This does not demonstrate that the lot meets the buyer’s 2 mg/kg maximum. An amount between the acceptance limit and the reporting threshold would still fall below that threshold.
- Report B states “below 0.5 mg/kg,” with an LOQ of 0.5 mg/kg. Its reporting capability is below the hypothetical limit. The quality team must still confirm analyte scope, method suitability, lot identity and the agreed decision rule before accepting the evidence.
Neither statement supplies an exact concentration. Do not enter zero or substitute the LOQ as a measured result. Preserve the laboratory’s original inequality or qualifier in the receiving record.

Align units, sample basis and method scope
For mass-fraction results, 1 mg/kg is numerically equivalent to 1 microgram per gram. A “ppm” label needs a clear basis; ask the laboratory to identify it rather than assuming all uses mean the same thing. Compare values only after confirming units and whether results are on a dried, as-supplied or other declared basis.
Sample preparation, extraction and analyte coverage matter alongside the numerical reporting limit. Ask which method revision was used, whether it is suitable for the offered extract, and how relevant interference is addressed. Where required by your approval process, request supporting method-performance information and an explanation of measurement uncertainty and the laboratory’s compliance decision rule. A named instrument alone is not a full analytical method.
Connect the report to the actual bulk lot
- Match the identifiers. Reconcile supplier lot, sample description, laboratory report number and dates with the COA and shipment records.
- Check the approved limit. Identify the specification revision and the exact analyte scope it requires. Confirm destination-market requirements with qualified personnel.
- Compare the evidence. Review result qualifiers, units, sample basis, reporting thresholds and method scope together.
- Resolve gaps before release. Request clarification, additional documentation or suitable testing through the approved QA process. Do not rewrite the supplier’s result to make it fit.
- Record the decision. Retain the original report, the reviewer and the reason for acceptance, hold or rejection. Define when a new lot or method change requires another review.
For U.S. dietary supplement operations, consult the applicable 21 CFR Part 111 cGMP requirements for production and recordkeeping context. They do not set the ginkgolic-acid acceptance limit in this hypothetical example.
Use the COA versus specification guide to separate approved requirements from lot results. The third-party test report guide addresses other contaminant-report checks; those results do not replace a ginkgolic-acid review.
Questions to include in a Ginkgo extract COA RFQ
Please identify the offered Ginkgo biloba leaf extract grade and provide its current specification and applicable lot COA. For ginkgolic acids, state the analytes covered, agreed maximum, units, reporting basis, method revision, LOD/LOQ or relevant reporting threshold, and the meaning of any ND or below-quantification statement. Confirm how the report is linked to the offered lot and which additional laboratory details are available for QA review.
Also request the separate marker assays, composition and applicable contaminant documentation. Confirm samples, packaging, MOQ and lead time for your quantity and destination through the B2B quote request. Available documents and supply terms require confirmation for the offered grade.
Frequently asked questions
Does ND mean that a ginkgo extract contains zero ginkgolic acids?
No. ND must be interpreted using the laboratory’s detection and reporting convention. Request the numerical threshold, analyte scope and method details before comparing it with a specification.
Can a below-LOQ result fail to demonstrate compliance?
Yes. If the LOQ exceeds the acceptance limit, an amount above that limit may still be below the LOQ. QA should review the method capability and approved decision rule rather than treating the qualifier as an automatic pass.
Do flavone-glycoside and terpene-lactone assays establish the ginkgolic-acid result?
No. These are separate review items. Obtain the applicable result and method information for ginkgolic acids as well as the marker assays and identity evidence.
Can the example limit in this guide be used as a purchasing standard?
No. The example is fictional and illustrates reporting-limit logic only. Establish the appropriate specification through qualified quality and regulatory review for the actual material, intended use and destination market.





